Market: NASD |
Currency: USD
Address: 409 Illinois Street
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Show more
📈 FibroGen, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$43.00
-
Upside/Downside from Analyst Target:
310.31%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
2025-11-11
-
EPS Estimate:
-4.00
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$0.040000 |
- |
2025-06-17 |
- |
Stock split |
|
Total Amount for 2025: $0.040000 |
📅 Earnings & EPS History for FibroGen, Inc.
| Date | Reported EPS |
|---|
| 2025-11-10 (estimated upcoming) | - |
| 2025-08-11 | -1.88 |
| 2025-05-12 | 1.25 |
| 2025-03-17 | -2 |
| 2024-11-12 | 0.37 |
| 2024-08-06 | -4 |
| 2024-05-06 | -8.25 |
| 2024-02-26 | -14.25 |
| 2023-11-06 | -12.98 |
| 2023-08-07 | -22.5 |
| 2023-05-08 | -20.25 |
| 2023-02-27 | -17.5 |
| 2022-11-07 | -24.5 |
| 2022-08-08 | -19.5 |
| 2022-05-09 | -17 |
| 2022-02-28 | -36.25 |
| 2021-11-09 | 13.5 |
| 2021-08-09 | -36.25 |
| 2021-05-10 | -19.5 |
| 2021-03-01 | -16 |
| 2020-11-05 | 8.75 |
| 2020-08-06 | -23.75 |
| 2020-05-07 | -22.25 |
| 2020-03-02 | -28 |
| 2019-11-11 | -14.25 |
📰 Related News & Research
No related articles found for "fibrogen inc".
